Multilineage involvement and erythropoietin-'independent' erythroid progenitor cells in a patient with systemic mastocytosis

Annals of Hematology

Volumn 77, Issue 4, 1998, Pages 183-186

  Afonja, O ^a   Amorosi, E ^a   Ashman, L ^b   Takeshita, K ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

c kit gene; Mutation; Tyrosine kinase

Indexed keywords

ERYTHROPOIETIN; STEM CELL FACTOR;

ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; HUMAN; HUMAN CELL; MALE; MYELOPROLIFERATIVE DISORDER; POINT MUTATION; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS;

CELL LINEAGE; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; HUMANS; MALE; MASTOCYTOSIS; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0031771070     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050439     Document Type: Article

References (18)

1. Anger B, Janssen JW, Schrezenmeier H, Hehlmann R, Heimpel H, Bartram CR (1990) Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia 4:258-261
2. Bernstein A, Forrester L, Reith AD, Dubreuil P, Rottapel R (1991) The murine W/c-kit and Steel loci and the control of hematopoiesis. Semin Hematol 28:138-142
3. Besmer P, Murphy JE, George PC, Qiu FH, Bergold PJ, Lederman L, Snyder HWJ, Brodeur D. Zuckerman EE, Hardy WD (1986) A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415-421
4. Coulombel L, Eaves A,Eaves C (1983) Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 62:291-299
5. Dai CH, Krantz SB, Means RTJ, Horn ST, Gilbert HS (1991) Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. J Clin Invest 87:391-396
6. Genovese A, Spadaro G, Triggiani M, Marone G (1995) Clinical advances in mastocytosis. Int J Clin Lab Res 25:178-188
7. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF (1991) Clonality in mycloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A 88:6848-6852
8. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, et al (1995) Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790-798
9. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, Okabe M, Suzuki M, Yamamura K, Matsuzawa Y, Kitamura Y, Kanakura Y (1996) Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 88:995-1004
10. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I (1996) Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature Genet 12:312-314
11. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A 92:10560-10564
12. Piao X, Paulson R, van der Greer P, Pawson T, Bernstein A (1996) Oncogenic mutation in the kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci U S A 93:14665-14669
13. Reid CD (1987) The significance of endogenous erythroid colonies (EEC) in haematological disorders. Blood Rev 1:133-140
14. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y (1994) Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619-2626
15. Van Zant G, Shultz L (1989) Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp Hematol 17:81-87
16. Wu H, Klingmuller U, Besmer P, Lodish HF (1995) Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377:242-246
17. Wu H, Klingmuller U, Acurio A, Hsiao JG, Lodish HF (1997) Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci U S A 94:1806-1810
18. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351